A Novel Metabolic Connectome Method to Predict Progression to Mild Cognitive Impairment
Objective. Glucose-based positron emission tomography (PET) imaging has been widely used to predict the progression of mild cognitive impairment (MCI) into Alzheimer’s disease (AD) clinically. However, existing discriminant methods are unsubtle to reveal pathophysiological changes. Therefore, we pre...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Behavioural Neurology |
Online Access: | http://dx.doi.org/10.1155/2020/2825037 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|